Leveraging Cytogenomics and Molecular Technologies to Complement Genomic Testing

From the 2023 Joint Annual Meeting (recorded 6/28/2023)
Presented by Wahab Khan, PhD, FACMG, and Lauren Wainman, PhD

Clinical case studies based around cytogenetic and molecular testing, ranging from combined use of karyotyping, FISH, chromosomal microarrays, and next generation sequencing, will be presented. The components of a genomic report will also be discussed.

LEARNING OBJECTIVES
At the conclusion of this presentation, participants will be able to:

  • Identify advantages and limitations of cytogenomic and molecular testing technologies.
  • Recognize situations in which reflexive or follow-up testing may be needed to better understand a cytogenetic or genomic finding.
  • Summarize content and interpretive categories of clinical genomic testing report, including somatic and germline testing.

CE ACCREDITATION
ASCLS is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the area of CMB (Cytogenetics) will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.

LEVEL OF INSTRUCTION
This Intermediate-level program is appropriate for laboratory professionals working in clinical, public health and academic settings.